Dr. Partridge, collaborators awarded NIH/NCI funding for new multicenter imaging trial

Congratulations to Savannah Partridge, Ph.D. and her collaborators at Oregon Health & Sciences University and University of Wisconsin-Madison on a new 5-year $2.5 million grant from the National Cancer Institute of the NIH to support their project titled, “Multicenter Quantitative MRI Assessment of Breast Cancer Therapy Response”. Per Dr. Partridge, “We will study the utility of novel imaging-based biomarkers to non-invasively assess treatment efficacy in women undergoing preoperative chemotherapy for breast cancer.” The UW/SCCA team consists of co-investigators Habib Rahbar, MD (radiology), Jennifer Specht, MD (medical oncology), and Suzanne Dintzis, MD, PhD (pathology) and they will work with collaborators at at OHSU and UW-Madison on the plan to validate and standardize this quantitative imaging technique across multiple institutions and MRI scanner platforms with a goal to accelerate translation into clinical trials and, ultimately, clinical practice for improving personalization of breast cancer therapy.